Anzeige
❌
Mehr »
Freitag, 20.11.2026 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PNDW | ISIN: CA63000Y1034 | Ticker: 1N1
Tradegate
18.11.26 | 20:13
0,071 Euro
+3,22 % +0,002
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
NANALYSIS SCIENTIFIC CORP Chart 1 Jahr
5-Tage-Chart
NANALYSIS SCIENTIFIC CORP 5-Tage-Chart
RealtimeGeldBriefZeit
0,0650,07317:02
0,0630,07416:50

Aktuelle News zur NANALYSIS SCIENTIFIC Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoNanalysis Announces Third Quarter 2026 Conference Call1
03.11.Nanalysis Scientific Corp: Nanalysis pays note interest in shares, CFO exits1
03.11.Nanalysis Settles Interest Payment on Promissory Notes and Provides Corporate Update3
NANALYSIS SCIENTIFIC Aktie jetzt für 0€ handeln
05.10.Nanalysis Scientific Corp: Nanalysis Scientific appoints Birkby interim CFO1
05.10.Nanalysis Scientific Corp.: Nanalysis Announces Management Changes282CALGARY, AB, Oct. 5, 2026 /PRNewswire/ -- Nanalysis Scientific Corp. (the "Company" or "Nanalysis") (TSXV: NSCI, FRA: 1N1) is pleased to announce the appointment...
► Artikel lesen
24.08.Earnings Call: Nanalysis Scientific verfehlt Q2-Prognosen - Aktie fällt1
24.08.Nanalysis Scientific verfehlt Q2-Prognosen - Aktie gibt deutlich nach2
24.08.Nanalysis Scientific reports Q2 results1
24.08.Nanalysis Scientific Corp.: Nanalysis Announces Second Quarter 2026 Results353Reports $9.7 Million in Quarterly Revenue and $0.9 Million in Adjusted EBITDA CALGARY, AB, Aug. 24, 2026 /PRNewswire/ -- Nanalysis Scientific Corp. ("the Company"...
► Artikel lesen
18.08.Nanalysis Scientific Corp: Nanalysis Scientific to release Q2 2026 results Aug. 241
18.08.Nanalysis Announces Second Quarter 2026 Conference Call1
03.07.Nanalysis Scientific Corp: Nanalysis grants option to buy 100,000 shares1
03.07.Nanalysis Announces Grant of Options and Restricted Share Units1
25.06.Nanalysis Scientific Corp: Nanalysis Scientific 883,333-share private placement1
23.06.Nanalysis Provides Business Update Highlighting Quantum Technology Partnerships, $1Million in Non-Dilutive Non-Repayable Funding Award, Contract Wins and Corporate Activities1
20.05.Nanalysis Scientific Corp.: Nanalysis Announces First Quarter 2026 Results296Reports Quarterly Revenue of $10.7 Million and Adjusted EBITDA of $292 Thousand CALGARY, AB, May 20, 2026 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company"...
► Artikel lesen
08.04.Nanalysis Scientific Corp.: Nanalysis Announces Fourth Quarter and Full Year 2025 Results438Reports Quarterly Revenue of $10.7 Million and Adjusted EBITDA of $1.2 Million Full Year Revenue of $40.1 Million and Adjusted EBITDA of $903 Thousand CALGARY,...
► Artikel lesen
26.01.Nanalysis Scientific Corp.: Nanalysis Announces Closing of Second Tranche to Complete its $3.4 Million Offering428CALGARY, AB, Jan. 26, 2026 /PRNewswire/ - Nanalysis Scientific Corp. (the "Company" or "Nanalysis") ( TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1 ) is pleased to...
► Artikel lesen
24.11.25Nanalysis Scientific Corp.: Nanalysis Announces Third Quarter 2025 Results627CALGARY, AB, Nov. 24, 2025 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR spectrometers...
► Artikel lesen
19 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1